Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes l-methioninase

Enzyme and Microbial Technology

Volumn 51, Issue 4, 2012, Pages 200-210

  El Sayed, Ashraf S ^a   Shouman, Samia A ^b   Nassrat, Hatem M ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Anticancer activity; Antigenicity; Aspergillus flavipes; L Methioninase; Pharmacokinetics

Indexed keywords

ABSORBANCES; ANTI-TUMOR EFFICACY; ANTICANCER ACTIVITIES; ANTIGENICITY; APO-ENZYMES; APPARENT VOLUME; ASPERGILLUS FLAVIPES; BIOCHEMICAL PROPERTIES; CATALYTIC PROPERTIES; CATALYTIC STRUCTURE; CELL CYCLE; CIRCULATION TIME; DNA METHYLATION; HEMATOLOGICAL PARAMETERS; HUMAN CANCER CELLS; IMMUNOGENICITY; IN-VITRO; IN-VIVO; L-METHIONINASE; NEUTRALIZING ANTIBODIES; NEW ZEALAND RABBITS; POLYAMINES; PSEUDOMONAS PUTIDA; SCHIFF-BASE; SPECTRAL STUDIES; TUMOR CELLS;

AMINO ACIDS; ASPERGILLUS; CELL CULTURE; FUNCTIONAL GROUPS; GLUCOSE; PHARMACOKINETICS; PLASMAS; SPECTROSCOPIC ANALYSIS;

ENZYME ACTIVITY;

ANTINEOPLASTIC AGENT; METHIONINE GAMMA LYASE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVIPES; CATALYSIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SINGLE DRUG DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS; ASPERGILLUS; CARBON-SULFUR LYASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; HALF-LIFE; HUMANS; LUNG NEOPLASMS; MALE; MCF-7 CELLS; METHIONINE; PROSTATIC NEOPLASMS; RABBITS;

ASPERGILLUS FLAVIPES; ORYCTOLAGUS CUNICULUS; PSEUDOMONAS PUTIDA;

EID: 84864958538     PISSN: 01410229     EISSN: 18790909     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2012.06.004     Document Type: Article

References (51)

1. Esaki N., Soda K. l-Methioninase γ-lyase from Pseudomonas putida and Aeromonas. Methods in Enzymology 1987, 143:459-465.
2. Soda A., Tanaka H., Esaki N. Multifunctional biocatlysis: methionine-γ-lyase. Trends in Biochemical Sciences 1983, 8:214-217.
3. Motoshima H., Inagaki K., kumasaka T., Furuichi M., Inoue H., Tamura T., et al. Crystal structure of the pyridoxal 5'-phosphate dependent l-methioninase γ-lyase from Pseudomonas putida. Journal of Biochemistry 2000, 128:349-354.
4. El-Sayed A.S.A. Purification and characterization of new l-methioninase from solid cultures of Aspergillus flavipes. Journal of Microbiology 2011, 49:130-140.
5. Kudou D., Misaki S., Yamashita M., Tamura T., Takakura T., Yoshioka T., et al. Structure of the antitumor enzyme l-methionine γ-lyase from Pseudomonas putida at 1.8Å resolution. Journal of Biochemistry 2007, 141:535-544.
6. Nikulin A., Revtovich S., Morozova E., Neveskaya N., Nikonov S., Garber M., et al. High resolution structure of methionine γ-lyase from Citrobacter freundii. Acta Crystallographica 2008, 64:211-218.
7. Sato D., Nozaki T. Methionine gamma-lyase: the unique reaction mechanism, physiological roles, and therapeutic applications against infectious disease and cancers. IUBMB Life 2009, 61:1019-1028.
8. El-Sayed A.S.A. Microbial l-methioninase, molecular characterization, and therapeutic applications. Applied Microbiology and Biotechnology 2010, 86:445-467.
9. Khalaf S.A., El-Sayed A.S.A. l-Methioninase production by filamentous fungi: screening and optimization under submerged conditions. Current Microbiology 2009, 58:219-226.
10. El-Sayed A.S.A. l-Methioninase production by Aspergillus flavipes: under solid state fermentation. Journal of Basic Microbiology 2009, 49:331-341.
11. Cooper A.J.L. Biochemistry of sulfur-containing amino acids. Annual Review of Biochemistry 1983, 52:187-222.
12. Hoffman R.M. Altered methionine metabolism, DNA methylation, and oncogene expression in carcinogenesis: a review and synthesis. Biochimica et Biophysica Acta 1984, 738:49-87.
13. Hoffman R.M., Erbe R.W. High in vivo rate of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proceedings of the National Academy of Sciences of the United States of America 1976, 73:1523-1527.
14. Goseki N., Yamazaki S., Shimojyo K., Kando F., Maruyama M., Endo M., et al. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer. A randomized, prospective clinical trial. Japanese Journal of Cancer Research 1995, 86:484-489.
15. Yamamoto N., Gupta A., Xu M., Miki K., Tsugimoto Y., Tsuchiya H., et al. Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells. Cancer Gene Therapy 2003, 10:445-450.
16. Kenyon S.H., Waterfield C.J., Timbrell J.A., Nicolaou A. Methionine synthase activity and sulphur amino acid levels in the rat liver tumor cells HTC and Phi-1. Biochemical Pharmacology 2002, 63:381-391.
17. Pegg A.E. Polyamine metabolism and its importance in neoplastic growth as a target for chemotherapy. Cancer Research 1988, 48:759-774.
18. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nature Reviews Genetics 2002, 3:415-428.
19. Zou C.G., Banerjee R. Homocysteine and redox signaling. Antioxidants and Redox Signalling 2005, 7:547-559.
20. Kokkinki D.M., Schold S.C., Hori H., Nobori T. Effect of long-term depletion of methionine on the growth and survival of human brain tumor xenografts in athymic mice. Nutrition and Cancer 1997, 29:195-204.
21. Miki K., Xu M., An Z., Wang X., Yang M., Al-Refaie W., et al. Survival efficacy of the combination of the methioninase gene and methioninase in a lung cancer orthotopic model. Nature 2000, 7:332-338.
22. Tan Y., Sun X., Xu M., An Z., Tan X., Tan X., et al. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy. Protein Expression and Purification 1998, 12:45-52.
23. Sun X., Yang Z., Li S., Tan Y., Zhang N., Wang X., et al. In vivo efficiency of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5-phosphate supplementation. Cancer Research 2003, 63:8377-8383.
24. Yang Z., wang J., Yoshioka T., Li B., Lu Q., Li S., et al. Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primates. Clinical Cancer Research 2004, 10:2131-2138.
25. Abuchowski A., Van E.S., Palczuk N.R., McCoy J.R., Davis F.F. Treatment of L5178Y tumor-bearing BD1 mice with a non-immunogenic l-glutaminase-l-asparaginase. Cancer Treatment Reports 1979, 63:1127-1132.
26. Holtsberg F.W., Ensor C.M., Steiner M.R., Bomalaski J.S., Clark M.A. Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. Journal of Controlled Release 2002, 80:259-271.
27. Pasut G., Veronese F.M. PEG conjugates in clinical development or use as anticancer agents: an overview. Advanced Drug Delivery Reviews 2009, 61:1177-1188.
28. El-Sayed A.S.A., Shindia A.A. Characterization and immobilization of purified Aspergillus flavipes l-methioninase: continuous production of methanethiol. Journal of Applied Microbiology 2011, 111:54-69.
29. Laakso S., Nurmikko V. A spectroscopic assay for determination activity. Analytical Biochemistry 1976, 72:600-605.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacterio-phage T4. Nature 1970, 227:680-685.
31. Jones B.N., Gilligan J.P. O-phthaldialdehyde precolumn derivatization and reversed phase high performance liquid chromatography of polypeptide hydrolysate and physiological fluids. Journal of Chromatography 1983, 266:471-482.
32. Yang Z., Wang J., Lu Q., Xu J., Kobayashi Y., Takakura T., et al. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates. Cancer Research 2004, 64:6673-6678.
33. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute 1990, 82:1107-1112.
34. Johnston M., Jankowski D., Marcotte P., Tanaka H., Esaki N., Soda K., et al. Suicide inactivation of bacterial cystathionine γ-synthase and methionine γ-lyase during processing of l-propargylglycine. Biochemistry 1979, 18:4690-4701.
35. Lishko V.K., Lishko O.V., Hoffman R.M. The preparation of endotoxin-free l-methionine-α-deamino-γ-mercaptomethane-lyase (l-methioninase) from Pseudomonas putida. Protein Expression and Purification 1993, 4:529-533.
36. Inoue H., Inagaki K., Sugimoto M., Esaki N., Soda K., Tanaka H. Structural analysis of the l-methionine γ-lyase gene from Pseudomonas putida. Journal of Biochemistry 1995, 117:1120-1125.
37. Tan Y., Xu M., Tan X., Tan X., Wang X., Saikawa Y., et al. Overexpression and large scale production of recombinant l-methionine α-deaminase γ-mercaptomethane-lyase for novel anticancer therapy. Protein Expression and Purification 1997, 9:223-245.
38. Epner D.E. Can dietray methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer. Journal of the American College of Nutrition 2001, 20:443S-449S.
39. Schellekens H. Immunogenicity of the therapeutic proteins: clinical implications and future prospects. Clinical Therapeutics 2002, 24:1720-1740.
40. Jevsevar S., Kunstelj M., Porekar V.G. PEGylation of therapeutic proteins. Biotechnology Journal 2010, 5:113-128.
41. Cantor J.R., Yoo T.H., Dixit A., Iverson B.L. Therapeutic enzyme deimmunization by combinational T-cell epitope removal using neutral drift. Proceedings of the National Academy of Sciences 2010, 25:1272-1277.
42. Hu J., Cheung N.-K.V. Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. International Journal of Cancer 2009, 124:1700-1706.
43. Kominami G., Agou T., Kanda A., Ohno M. Immunoenzymometric assay for recombinant methioninase in biological fluids. Journal of Pharmaceutical and Biomedical Analysis 2002, 30:733-738.
44. Yang Z., Sun X., Li S., Tan Y., Wang X., Zhang N., et al. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5-phosphate. Cancer Research 2004, 64:5775-5778.
45. Guo H., Lishko V., Herrera H., Groce A., Kubota T., Hoffman R.M. Therapeutic tumor specific cell-cycle block induced by methionine starvation in vivo. Cancer Research 1993, 53:5676-5679.
46. Lu S., Epner D.E. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutrition and Cancer 2001, 38:123-130.
47. Yoshioka T., Wada T., Uchida N., Maki H., Yoshida H., Ide N., et al. Anticancer efficiency in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Research 1998, 58:2583-2587.
48. Bertadoli M., Cellii B., Clausen T., Voltattorni C.B. Spectroscopic and kinetic analyses reveals the pyridoxal 5-phosphate binding mode and catalytic features of Treponema denticola. Biochemistry 2002, 41:9153-9164.
49. Walsh C., Garneau T.S., Gatto G.J. Protein posttranslational modifications: the chemistry of proteome diversifications. Angewandte Chemie International 2005, 44:7342-7372.
50. Hori H., Takabayashi K., Orvis L., Carson D.A., Nobori T. Gene cloning and characterization of Pseudomonas putida l-methionine-α-deamino-γ-mercaptomethane-lyase. Cancer Research 1996, 56:2116-2122.
51. Tan Y., Xu M., Hoffman R.M. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells in vitro. Anticancer Research 2010, 30:1041-1046.